Giuseppe Di Giovanni - Publications

Affiliations: 
Physiology and Biochemestry Malta University, Malta. Cardiff University, UK., Cardiff, Wales, United Kingdom 
Area:
Dopamine and serotonin physiopathology
Website:
http://www.um.edu.mt/ms/physbiochem

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Deidda G, Pierucci M, Crunelli V, Di Giovanni G. 5-HT/GABA interaction in neurodevelopment and plasticity. Progress in Brain Research. 259: 287-317. PMID 33541680 DOI: 10.1016/bs.pbr.2021.01.009  1
2021 Deidda G, Crunelli V, Di Giovanni G. 5-HT/GABA interaction in epilepsy. Progress in Brain Research. 259: 265-286. PMID 33541679 DOI: 10.1016/bs.pbr.2021.01.008  1
2020 Crunelli V, Lőrincz ML, McCafferty C, Lambert RC, Leresche N, Di Giovanni G, David F. Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures. Brain : a Journal of Neurology. PMID 32437558 DOI: 10.1093/Brain/Awaa072  1
2018 Colangeli R, Pierucci M, Benigno A, Campiani G, Butini S, Di Giovanni G. Author Correction: The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity. Scientific Reports. 8: 17977. PMID 30546129 DOI: 10.1038/s41598-018-37392-y  0.68
2018 Di Giovanni G, Crunelli V, Rizzolatti G. Interdisciplinary approaches for neuropathology. Cns Neuroscience & Therapeutics. 24: 665-668. PMID 30009529 DOI: 10.1111/cns.13004  1
2018 David F, Çarçak N, Furdan S, Onat F, Gould T, Mészáros Á, Di Giovanni G, Hernández VM, Chan CS, Lőrincz ML, Crunelli V. Suppression of HCN channel function in thalamocortical neurons prevents genetically determined and pharmacologically induced absence seizures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29925625 DOI: 10.1523/Jneurosci.0896-17.2018  1
2018 McCafferty C, David F, Venzi M, Lőrincz ML, Delicata F, Atherton Z, Recchia G, Orban G, Lambert RC, Di Giovanni G, Leresche N, Crunelli V. Cortical drive and thalamic feed-forward inhibition control thalamic output synchrony during absence seizures. Nature Neuroscience. PMID 29662216 DOI: 10.1038/S41593-018-0130-4  1
2018 Colangeli R, Pierucci M, Benigno A, Campiani G, Butini S, Di Giovanni G. Author Correction: The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity. Scientific Reports. 8: 4648. PMID 29531281 DOI: 10.1038/s41598-018-23084-0  0.68
2018 Delicata F, Bombardi C, Pierucci M, Di Maio R, De Deurwaerdère P, Di Giovanni G. Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence. Cns Neuroscience & Therapeutics. PMID 29479825 DOI: 10.1111/cns.12830  0.68
2018 Bombardi C, Venzi M, Crunelli V, Di Giovanni G. Developmental changes of GABA immunoreactivity in cortico-thalamic networks of an absence seizure model. Neuropharmacology. PMID 29471054 DOI: 10.1016/j.neuropharm.2018.01.047  1
2017 Colangeli R, Pierucci M, Benigno A, Campiani G, Butini S, Di Giovanni G. The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity. Scientific Reports. 7: 11152. PMID 28894217 DOI: 10.1038/s41598-017-11606-1  0.68
2016 Venzi M, David F, Bellet J, Cavaccini A, Bombardi C, Crunelli V, Di Giovanni G. Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures. Neuropharmacology. PMID 27085605 DOI: 10.1016/J.Neuropharm.2016.04.016  1
2015 Di Giovanni G, De Deurwaerdère P. New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders. Pharmacology & Therapeutics. PMID 26617215 DOI: 10.1016/j.pharmthera.2015.11.009  1
2015 Crunelli V, Di Giovanni G. Differential Control by 5-HT and 5-HT1A, 2A, 2C Receptors of Phasic and Tonic GABAA Inhibition in the Visual Thalamus. Cns Neuroscience & Therapeutics. PMID 26555767 DOI: 10.1111/cns.12480  1
2015 Navailles S, Di Giovanni G, De Deurwaerdère P. The 5-HT4 Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo. Cns Neuroscience & Therapeutics. 21: 745-7. PMID 26205756 DOI: 10.1111/cns.12436  1
2015 Casarrubea M, Davies C, Faulisi F, Pierucci M, Colangeli R, Partridge L, Chambers S, Cassar D, Valentino M, Muscat R, Benigno A, Crescimanno G, Di Giovanni G. Acute nicotine induces anxiety and disrupts temporal pattern organization of rat exploratory behavior in hole-board: a potential role for the lateral habenula. Frontiers in Cellular Neuroscience. 9: 197. PMID 26082682 DOI: 10.3389/fncel.2015.00197  1
2015 Marino Gammazza A, Colangeli R, Orban G, Pierucci M, Di Gennaro G, Lo Bello M, D'Aniello A, Bucchieri F, Pomara C, Valentino M, Muscat R, Benigno A, Zummo G, de Macario EC, Cappello F, ... Di Giovanni G, et al. Hsp60 response in experimental and human temporal lobe epilepsy. Scientific Reports. 5: 9434. PMID 25801186 DOI: 10.1038/srep09434  1
2015 Venzi M, Di Giovanni G, Crunelli V. A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures. Cns Neuroscience & Therapeutics. 21: 123-40. PMID 25403866 DOI: 10.1111/cns.12337  1
2015 Casarrubea M, Jonsson GK, Faulisi F, Sorbera F, Di Giovanni G, Benigno A, Crescimanno G, Magnusson MS. T-pattern analysis for the study of temporal structure of animal and human behavior: a comprehensive review. Journal of Neuroscience Methods. 239: 34-46. PMID 25280983 DOI: 10.1016/j.jneumeth.2014.09.024  1
2014 D'Adamo MC, Gallenmüller C, Servettini I, Hartl E, Tucker SJ, Arning L, Biskup S, Grottesi A, Guglielmi L, Imbrici P, Bernasconi P, Di Giovanni G, Franciolini F, Catacuzzeno L, Pessia M, et al. Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene. Frontiers in Physiology. 5: 525. PMID 25642194 DOI: 10.3389/Fphys.2014.00525  1
2014 Godar SC, Mosher LJ, Di Giovanni G, Bortolato M. Animal models of tic disorders: a translational perspective. Journal of Neuroscience Methods. 238: 54-69. PMID 25244952 DOI: 10.1016/J.Jneumeth.2014.09.008  1
2014 Taylor H, Schmiedt JT, Carçak N, Onat F, Di Giovanni G, Lambert R, Leresche N, Crunelli V, David F. Investigating local and long-range neuronal network dynamics by simultaneous optogenetics, reverse microdialysis and silicon probe recordings in vivo. Journal of Neuroscience Methods. 235: 83-91. PMID 25004203 DOI: 10.1016/J.Jneumeth.2014.06.031  1
2014 Orban G, Bombardi C, Marino Gammazza A, Colangeli R, Pierucci M, Pomara C, Pessia M, Bucchieri F, Benigno A, Arcangelo B, Smolders I, De Deurwaerdère P, Di Giovanni G. Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats. Cns Neuroscience & Therapeutics. 20: 651-61. PMID 24935789 DOI: 10.1111/cns.12285  1
2014 Di Giovanni G, García I, Colangeli R, Pierucci M, Rivadulla ML, Soriano E, Chioua M, Della Corte L, Yáñez M, De Deurwaerdère P, Fall Y, Marco-Contelles J. N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties. Cns Neuroscience & Therapeutics. 20: 633-40. PMID 24848125 DOI: 10.1111/cns.12284  1
2014 Navailles S, Milan L, Khalki H, Di Giovanni G, Lagière M, De Deurwaerdère P. Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats. Cns Neuroscience & Therapeutics. 20: 671-8. PMID 24775184 DOI: 10.1111/cns.12275  1
2014 Aourz N, Portelli J, Coppens J, De Bundel D, Di Giovanni G, Van Eeckhaut A, Michotte Y, Smolders I. Cortistatin-14 mediates its anticonvulsant effects via sst2 and sst3 but not ghrelin receptors. Cns Neuroscience & Therapeutics. 20: 662-70. PMID 24685142 DOI: 10.1111/cns.12259  1
2014 Navailles S, Di Giovanni G, De Deurwaerdère P. Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease. Cns Neuroscience & Therapeutics. 20: 699-701. PMID 24628826 DOI: 10.1111/cns.12252  1
2014 Crunelli V, Di Giovanni G. Monoamine modulation of tonic GABAA inhibition. Reviews in the Neurosciences. 25: 195-206. PMID 24468610 DOI: 10.1515/revneuro-2013-0059  1
2013 David F, Schmiedt JT, Taylor HL, Orban G, Di Giovanni G, Uebele VN, Renger JJ, Lambert RC, Leresche N, Crunelli V. Essential thalamic contribution to slow waves of natural sleep. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19599-610. PMID 24336724 DOI: 10.1523/Jneurosci.3169-13.2013  1
2013 Connelly WM, Errington AC, Di Giovanni G, Crunelli V. Metabotropic regulation of extrasynaptic GABAA receptors. Frontiers in Neural Circuits. 7: 171. PMID 24298239 DOI: 10.3389/Fncir.2013.00171  1
2013 Van Liefferinge J, Massie A, Portelli J, Di Giovanni G, Smolders I. Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy? Frontiers in Cellular Neuroscience. 7: 139. PMID 24009559 DOI: 10.3389/fncel.2013.00139  1
2013 Orban G, Pierucci M, Benigno A, Pessia M, Galati S, Valentino M, Muscat R, Di Giovanni G. High dose of 8-OH-DPAT decreases maximal dentate gyrus activation and facilitates granular cell plasticity in vivo. Experimental Brain Research. 230: 441-51. PMID 23780309 DOI: 10.1007/s00221-013-3594-1  1
2013 Yagüe JG, Cavaccini A, Errington AC, Crunelli V, Di Giovanni G. Dopaminergic modulation of tonic but not phasic GABAA-receptor-mediated current in the ventrobasal thalamus of Wistar and GAERS rats. Experimental Neurology. 247: 1-7. PMID 23562670 DOI: 10.1016/j.expneurol.2013.03.023  1
2013 Connelly WM, Fyson SJ, Errington AC, McCafferty CP, Cope DW, Di Giovanni G, Crunelli V. GABAB Receptors Regulate Extrasynaptic GABAA Receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 3780-5. PMID 23447590 DOI: 10.1523/Jneurosci.4989-12.2013  1
2011 Pierucci M, Galati S, Valentino M, Di Matteo V, Benigno A, Pitruzzella A, Muscat R, Di Giovanni G. Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Cns & Neurological Disorders Drug Targets. 10: 777-91. PMID 21999732  0.68
2011 Errington AC, Di Giovanni G, Crunelli V, Cope DW. mGluR control of interneuron output regulates feedforward tonic GABAA inhibition in the visual thalamus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 8669-80. PMID 21653871 DOI: 10.1523/JNEUROSCI.0317-11.2011  1
2010 Di Matteo V, Pierucci M, Benigno A, Esposito E, Crescimanno G, Di Giovanni G. Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats. Cns Neuroscience & Therapeutics. 16: 127-36. PMID 20345972 DOI: 10.1111/j.1755-5949.2010.00136.x  0.68
2009 di Matteo V, Pierucci M, Di Giovanni G, Dragani LK, Murzilli S, Poggi A, Esposito E. Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons. Journal of Neural Transmission. Supplementum. 333-41. PMID 20411791  0.68
2009 Di Matteo V, Pierucci M, Benigno A, Orbán G, Crescimanno G, Esposito E, Di Giovanni G. Electrophysiological and neurochemical characterization of 7-nitroindazole and molsidomine acute and sub-chronic administration effects in the dopaminergic nigrostrial system in rats. Journal of Neural Transmission. Supplementum. 173-82. PMID 20411777  0.68
2009 Cope DW, Di Giovanni G, Fyson SJ, Orbán G, Errington AC, Lorincz ML, Gould TM, Carter DA, Crunelli V. Enhanced tonic GABAA inhibition in typical absence epilepsy. Nature Medicine. 15: 1392-8. PMID 19966779 DOI: 10.1038/nm.2058  1
2009 Abdallah L, Bonasera SJ, Hopf FW, O'Dell L, Giorgetti M, Jongsma M, Carra S, Pierucci M, Di Giovanni G, Esposito E, Parsons LH, Bonci A, Tecott LH. Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8156-65. PMID 19553455 DOI: 10.1523/Jneurosci.3905-08.2009  1
2009 Balosso S, Ravizza T, Pierucci M, Calcagno E, Invernizzi R, Di Giovanni G, Esposito E, Vezzani A. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience. 161: 293-300. PMID 19285115 DOI: 10.1016/j.neuroscience.2009.03.005  0.68
2009 Pierucci M, Di Matteo V, Benigno A, Crescimanno G, Esposito E, Di Giovanni G. The unilateral nigral lesion induces dramatic bilateral modification on rat brain monoamine neurochemistry. Annals of the New York Academy of Sciences. 1155: 316-23. PMID 19250223 DOI: 10.1111/j.1749-6632.2008.03679.x  0.68
2009 Di Matteo V, Pierucci M, Benigno A, Crescimanno G, Esposito E, Di Giovanni G. Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study . Annals of the New York Academy of Sciences. 1155: 309-15. PMID 19250222 DOI: 10.1111/j.1749-6632.2008.03678.x  0.68
2008 Di Matteo V, Pierucci M, Esposito E, Crescimanno G, Benigno A, Di Giovanni G. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Progress in Brain Research. 172: 423-63. PMID 18772045 DOI: 10.1016/S0079-6123(08)00921-7  0.68
2008 Di Giovanni G, Di Matteo V, Pierucci M, Esposito E. Serotonin-dopamine interaction: electrophysiological evidence. Progress in Brain Research. 172: 45-71. PMID 18772027 DOI: 10.1016/S0079-6123(08)00903-5  0.68
2008 Di Matteo V, Di Giovanni G, Pierucci M, Esposito E. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Progress in Brain Research. 172: 7-44. PMID 18772026 DOI: 10.1016/S0079-6123(08)00902-3  0.68
2007 Di Matteo V, Pierucci M, Di Giovanni G, Benigno A, Esposito E. The neurobiological bases for the pharmacotherapy of nicotine addiction. Current Pharmaceutical Design. 13: 1269-84. PMID 17504235  0.68
2007 Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G. Non-steroidal anti-inflammatory drugs in Parkinson's disease. Experimental Neurology. 205: 295-312. PMID 17433296 DOI: 10.1016/j.expneurol.2007.02.008  0.68
2007 Invernizzi RW, Pierucci M, Calcagno E, Di Giovanni G, Di Matteo V, Benigno A, Esposito E. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience. 144: 1523-35. PMID 17161544 DOI: 10.1016/j.neuroscience.2006.11.004  0.68
2006 Di Matteo V, Benigno A, Pierucci M, Giuliano DA, Crescimanno G, Esposito E, Di Giovanni G. 7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study. Annals of the New York Academy of Sciences. 1089: 462-71. PMID 17261789 DOI: 10.1196/annals.1386.015  1
2006 Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, Esposito E. Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies? Current Medicinal Chemistry. 13: 3069-81. PMID 17073648  0.68
2006 Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, Esposito E. Central serotonin2C receptor: from physiology to pathology. Current Topics in Medicinal Chemistry. 6: 1909-25. PMID 17017966  0.68
2006 Di Matteo V, Pierucci M, Di Giovanni G, Di Santo A, Poggi A, Benigno A, Esposito E. Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study. Brain Research. 1095: 167-77. PMID 16712818 DOI: 10.1016/j.brainres.2006.04.013  1
Show low-probability matches.